An Extremely Rare Cause of Wolff-Parkinson
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Constrictive Pericarditis Causing Ventricular Tachycardia.Pdf
EP CASE REPORT ....................................................................................................................................................... A visually striking calcific band causing monomorphic ventricular tachycardia as a first presentation of constrictive pericarditis Kian Sabzevari 1*, Eva Sammut2, and Palash Barman1 1Bristol Heart Institute, UH Bristol NHS Trust UK, UK; and 2Bristol Heart Institute, UH Bristol NHS Trust UK & University of Bristol, UK * Corresponding author. Tel: 447794900287; fax: 441173425926. E-mail address: [email protected] Introduction Constrictive pericarditis (CP) is a rare condition caused by thickening and stiffening of the pericar- dium manifesting in dia- stolic dysfunction and enhanced interventricu- lar dependence. In the developed world, most cases are idiopathic or are associated with pre- vious cardiac surgery or irradiation. Tuberculosis remains a leading cause in developing areas.1 Most commonly, CP presents with symptoms of heart failure and chest discomfort. Atrial arrhythmias have been described as a rare pre- sentation, but arrhyth- mias of ventricular origin have not been reported. Figure 1 (A) The 12 lead electrocardiogram during sustained ventricular tachycardia is shown; (B and C) Case report Different projections of three-dimensional reconstructions of cardiac computed tomography demonstrating a A 49-year-old man with a striking band of calcification around the annulus; (D) Carto 3DVR mapping—the left hand panel (i) demonstrates a background of diabetes, sinus beat with late potentials at the point of ablation in the coronary sinus, the right hand panel (iii) shows the hypertension, and hyper- pacemap with a 89% match to the clinical tachycardia [matching the morphology seen on 12 lead ECG (A)], and cholesterolaemia and a the middle panel (ii) displays the three-dimensional voltage map. -
What Are Premature Ventricular Contractions?
What Are Premature Ventricular Contractions? Premature ventricular contractions (VPCs or PVCs) are irregular beats that originate from the heart’s pumping chambers (ventricles). These beats interrupt the normal regular (sinus) rhythm, and result in irregularity to the heart rhythm. Although single PVCs are not life- threatening, they may indicate the presence of underlying heart disease, or when they become more severe can cause rapid and dangerous increases in heart rate (ventricular tachycardia). WHAT CAUSES PREMATURE VENTRICULAR CONTRACTIONS? PVCs can occur secondary to a variety of causes, most concerning being cardiac disease. PVCs are most commonly seen in dogs with Dilated Cardiomyopathy, but can also occur in the later stages of disease with Myxomatous Mitral Valve Degeneration. PVCs and other ventricular arrhythmias can also with no evidence of underlying structural heart disease. The workup for PVCs can be frustrating, because PVCs can also occur secondary to conditions unrelated to the heart. Most commonly they can occur secondary to gastrointestinal disease, systemic disease, and pain. HOW ARE PREMATURE VENTRICULAR CONTRACTIONS DIAGNOSED? Most commonly, your veterinarian will hear an irregular heart rhythm and recommend an electrocardiogram (ECG) to assess the heart rhythm. The ECG will enable your veterinarian to determine whether the irregular rhythm is due to PVCs. Following this diagnosis, there are several additional recommended tests. TESTING Following this diagnosis, there are several additional recommended tests. ECHOCARDIOGRAPHY Echocardiography (heart ultrasound) is recommended to make sure that there is no evidence of structural cardiac disease causing the abnormal heart rhythm. 24-HOUR HOLTER Single PVCs usually do not require treatment, however a Holter monitor will determine whether the frequency or severity of the MONITOR PVCs warrant anti-arrhythmic medication, and make sure that there is no evidence of ventricular tachycardia, which is a life threatening heart rhythm. -
Basic Rhythm Recognition
Electrocardiographic Interpretation Basic Rhythm Recognition William Brady, MD Department of Emergency Medicine Cardiac Rhythms Anatomy of a Rhythm Strip A Review of the Electrical System Intrinsic Pacemakers Cells These cells have property known as “Automaticity”— means they can spontaneously depolarize. Sinus Node Primary pacemaker Fires at a rate of 60-100 bpm AV Junction Fires at a rate of 40-60 bpm Ventricular (Purkinje Fibers) Less than 40 bpm What’s Normal P Wave Atrial Depolarization PR Interval (Normal 0.12-0.20) Beginning of the P to onset of QRS QRS Ventricular Depolarization QRS Interval (Normal <0.10) Period (or length of time) it takes for the ventricles to depolarize The Key to Success… …A systematic approach! Rate Rhythm P Waves PR Interval P and QRS Correlation QRS Rate Pacemaker A rather ill patient……… Very apparent inferolateral STEMI……with less apparent complete heart block RATE . Fast vs Slow . QRS Width Narrow QRS Wide QRS Narrow QRS Wide QRS Tachycardia Tachycardia Bradycardia Bradycardia Regular Irregular Regular Irregular Sinus Brady Idioventricular A-Fib / Flutter Bradycardia w/ BBB Sinus Tach A-Fib VT PVT Junctional 2 AVB / II PSVT A-Flutter SVT aberrant A-Fib 1 AVB 3 AVB A-Flutter MAT 2 AVB / I or II PAT PAT 3 AVB ST PAC / PVC Stability Hypotension / hypoperfusion Altered mental status Chest pain – Coronary ischemic Dyspnea – Pulmonary edema Sinus Rhythm Sinus Rhythm P Wave PR Interval QRS Rate Rhythm Pacemaker Comment . Before . Constant, . Rate 60-100 . Regular . SA Node Upright in each QRS regular . Interval =/< leads I, II, . Look . Interval .12- .10 & III alike .20 Conduction Image reference: Cardionetics/ http://www.cardionetics.com/docs/healthcr/ecg/arrhy/0100_bd.htm Sinus Pause A delay of activation within the atria for a period between 1.7 and 3 seconds A palpitation is likely to be felt by the patient as the sinus beat following the pause may be a heavy beat. -
PAROXYSMAL VENTRICULAR TACHYCARDIA OCCURRING in a NORMAL HEART by DAVID ROMNEY, M.B., B.Ch.(Dub.) Ex-Senior House Officer in Medicine, St
Postgrad Med J: first published as 10.1136/pgmj.31.354.191 on 1 April 1955. Downloaded from I9I -J PAROXYSMAL VENTRICULAR TACHYCARDIA OCCURRING IN A NORMAL HEART By DAVID ROMNEY, M.B., B.Ch.(Dub.) Ex-Senior House Officer in Medicine, St. James's Hospital, Balham It is widely taught-and rightly so-that by sinus pressure will, of course, not affect the paroxysmal ventricular tachycardia is one of the rate in ventricular tachycardia. rarer arrhythmias, and is associated with grave In I953 Froment, Gallavardin and Cahen myocardial damage, with special reference to myo- offered a classification of various forms of cardial infarction. It is the least common, and paroxysmal ventricular tachycardia, and included most serious of the paroxysmal tachycardias, some case report. They described the following which contain four varieties of arrhythmia: supra- groups:- ventricular (auricular and nodal) 60 per cent.; (i) Terminal prefibrillatory ventricular tachy- auricular fibrillation, 30 per cent.; auricular flutter, cardia. 6 per cent.; and ventricular tachycardia, 4 per (ii) Curable and mild monomorphic extra- cent. systoles, with paroxysms of tachycardia. Figures from various sources (Campbell, 1947) (iii) Paroxysmal ventricular tachycardia due toby copyright. would indicate that in the latter group, four-fifths a lesion of the ventricular septum. of the cases had seriously damaged hearts. In (iv) Persistent and prolonged ventricular tachy- the remaining fifth no cause was found for the cardia developing in sound hearts, usually paroxysms. Paroxysmal ventricular tachycardia is in young subjects. more common in men than in women in the proportion of about 3.2. This arrhythmia was Case Report first identified by Sir Thomas Lewis in I909 and A married woman, aged 48, first became aware Gallavardin (1920, I921, 1922) emphasized the in 1948 of a paroxysm which caused alarm, faint- seriousness of the 'terminal ven- ness and It lasted a short pre-fibrillatory collapse. -
The Example of Short QT Syndrome Jules C
Hancox et al. Journal of Congenital Cardiology (2019) 3:3 Journal of https://doi.org/10.1186/s40949-019-0024-7 Congenital Cardiology REVIEW Open Access Learning from studying very rare cardiac conditions: the example of short QT syndrome Jules C. Hancox1,4* , Dominic G. Whittaker2,3, Henggui Zhang4 and Alan G. Stuart5,6 Abstract Background: Some congenital heart conditions are very rare. In a climate of limited resources, a viewpoint could be advanced that identifying diagnostic criteria for such conditions and, through empiricism, effective treatments should suffice and that extensive mechanistic research is unnecessary. Taking the rare but dangerous short QT syndrome (SQTS) as an example, this article makes the case for the imperative to study such rare conditions, highlighting that this yields substantial and sometimes unanticipated benefits. Genetic forms of SQTS are rare, but the condition may be under-diagnosed and carries a risk of sudden death. Genotyping of SQTS patients has led to identification of clear ion channel/transporter culprits in < 30% of cases, highlighting a role for as yet unidentified modulators of repolarization. For example, recent exome sequencing in SQTS has identified SLC4A3 as a novel modifier of ventricular repolarization. The need to distinguish “healthy” from “unhealthy” short QT intervals has led to a search for additional markers of arrhythmia risk. Some overlap may exist between SQTS, Brugada Syndrome, early repolarization and sinus bradycardia. Genotype-phenotype studies have led to identification of arrhythmia substrates and both realistic and theoretical pharmacological approaches for particular forms of SQTS. In turn this has increased understanding of underlying cardiac ion channels. -
Ventricular Tachycardia Drugs Versus Devices John Camm St
Cardiology Update 2015 Davos, Switzerland: 8-12th February 2015 Ventricular Arrhythmias Ventricular Tachycardia Drugs versus Devices John Camm St. George’s University of London, UK Imperial College, London, UK Declaration of Interests Chairman: NICE Guidelines on AF, 2006; ESC Guidelines on Atrial Fibrillation, 2010 and Update, 2012; ACC/AHA/ESC Guidelines on VAs and SCD; 2006; NICE Guidelines on ACS and NSTEMI, 2012; NICE Guidelines on heart failure, 2008; NICE Guidelines on Atrial Fibrillation, 2006; ESC VA and SCD Guidelines, 2015 Steering Committees: multiple trials including novel anticoagulants DSMBs: multiple trials including BEAUTIFUL, SHIFT, SIGNIFY, AVERROES, CASTLE- AF, STAR-AF II, INOVATE, and others Events Committees: one trial of novel oral anticoagulants and multiple trials of miscellaneous agents with CV adverse effects Editorial Role: Editor-in-Chief, EP-Europace and Clinical Cardiology; Editor, European Textbook of Cardiology, European Heart Journal, Electrophysiology of the Heart, and Evidence Based Cardiology Consultant/Advisor/Speaker: Astellas, Astra Zeneca, ChanRX, Gilead, Merck, Menarini, Otsuka, Sanofi, Servier, Xention, Bayer, Boehringer Ingelheim, Bristol- Myers Squibb, Daiichi Sankyo, Pfizer, Boston Scientific, Biotronik, Medtronic, St. Jude Medical, Actelion, GlaxoSmithKline, InfoBionic, Incarda, Johnson and Johnson, Mitsubishi, Novartis, Takeda Therapy for Ventricular Tachycardia Medical therapy Antiarrhythmic drugs Autonomic management Ventricular tachycardia Monomorphic Polymorphic Ventricular fibrillation Ventricular storms Ablation therapy Device therapy Surgical Defibrillation Catheter Antitachycardia pacing History of Antiarrhythmic Drugs 1914 - Quinidine 1950 - Lidocaine 1951 - Procainamide 1946 – Digitalis 1956 – Ajmaline 1962 - Verapamil 1962 – Disopyramide 1964 - Propranolol 1967 – Amiodarone 1965 – Bretylium 1972 – Mexiletine 1973 – Aprindine, Tocainide 1969 - Diltiazem 1975- Flecainide 1976 – Propafenone Encainide Ethmozine 2000 - Sotalol D-sotalol 1995 - Ibutilide (US) Recainam 2000 – Dofetilide US) IndecainideX Etc. -
Sinus Node Ischemia—A Unique Presentation
International Journal of Clinical Medicine, 2015, 6, 50-54 Published Online January 2015 in SciRes. http://www.scirp.org/journal/ijcm http://dx.doi.org/10.4236/ijcm.2015.61007 Sinus Node Ischemia—A Unique Presentation Jwalit Morakhia1, Padmakumar Ramachandran1, Naveen Chandra Ganiga Sanjeeva1, Harikrishna Damodaran2, Shivani Kothari3, Ashok Thakkar3 1Department of Cardiology, Kasturba Medical College & Hospital, Karnataka, India 2Department of Cardiology, Pariyaram Medical College, Kerala, India 3Department of Clinical Trials, Sahajanand Medical Technologies Pvt. Ltd., Gujarat, India Email: [email protected] Received 27 December 2014; accepted 13 January 2015; published 20 January 2015 Copyright © 2015 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract Sinus node dysfunction, as the sole manifestation of an acute coronary syndrome, is rare. We re- port a case of ischemic dysfunction of the sinus node in a patient who had previously undergone coronary artery bypass grafting for triple vessel disease. Intermittent rest angina with a junctional rhythm was noted in spite of patent grafts to all three vessels, which resolved after percutaneous revascularization of the right coronary artery. Keywords Sinus Node, Angina, Acute Coronary Syndrome, Thrombus Aspiration 1. Introduction Patients presenting with acute coronary syndromes, with atypical symptoms, are frequently misdiagnosed and under-treated. Embolic phenomena are sometimes overlooked by interventionalists as percutaneous coronary intervention is a specialty which primarily focuses on stenosis and occlusions [1]. We report a case of reversible sinus node dysfunction in the unique setting of post-coronary artery bypass grafting (CABG) status with patent grafts. -
First Degree Atrioventricular Block Patrick Loftis Marquette University, [email protected]
Marquette University e-Publications@Marquette Physician Assistant Studies Faculty Research and Physician Assistant Studies, Department Publications 1-21-2011 First Degree Atrioventricular Block Patrick Loftis Marquette University, [email protected] James F. Ginter Aurora Cardiovascular Services Published version. Journal of the American Academy of Physician Assistants, Vol. 24, No. 1 (January 2011). Permalink. © 2011, American Academy of Physician Assistants and Haymarket Media Inc. Used with permission. First-degree atrioventricular blocks - Print Article - JAAPA http://www.jaapa.com/first-degree-atrioventricular-blocks/printarticle/1... << Return to First-degree atrioventricular blocks Patrick Loftis, PA-C, MPAS, RN, James F. Ginter, MPAS, PA-C January 21 2011 An atrioventricular (AV) block is a common cardiac abnormality. It involves a slowing or blockage of the electrical impulse coming from the sinoatrial (SA) node at or around the AV node (Figure 1). AV blocks are characterized by the slowing or partial or complete blocking of the impulse. This discussion will focus on first- degree atrioventricular block, which is the slowing or partial blocking of the impulse; complete blockade will be discussed in a future segment of this department. Despite the name, no impulse is actually blocked in first-degree AV block. Instead, each impulse is simply slowed at or near the atrioventricular node. On an ECG, AV block is manifested by a prolonged PR interval, which is measured from the beginning of the P wave to the beginning of the QRS complex. The ECG criterion for a first-degree atrioventricular block is a PR interval greater than 200 milliseconds. Symptoms First-degree AV block by itself does not result in symptoms. -
Atrioventricular Block in Children with Multisystem Inflammatory Syndrome Audrey Dionne, Douglas Y
Atrioventricular Block in Children With Multisystem Inflammatory Syndrome Audrey Dionne, MD,a,b Douglas Y. Mah, MD,a,b Mary Beth F. Son, MD,b,c Pui Y. Lee, MD, PhD,b,c Lauren Henderson, MD, MMSc,b,c Annette L. Baker, MSC, PNP,a,b Sarah D. de Ferranti, MD,a,b David R. Fulton, MD,a,b Jane W. Newburger, MD, MPH,a,b Kevin G. Friedman, MDa,b BACKGROUND: Children are at risk for multisystem inflammatory syndrome in children (MIS-C) abstract after infection with severe acute respiratory syndrome coronavirus 2. Cardiovascular complications, including ventricular dysfunction and coronary dilation, are frequent, but there are limited data on arrhythmic complications. METHODS: Retrospective cohort study of children and young adults aged #21 years admitted with MIS-C. Demographic characteristics, electrocardiogram (ECG) and echocardiogram findings, and hospital course were described. RESULTS: Among 25 patients admitted with MIS-C (60% male; median age 9.7 [interquartile range 2.7–15.0] years), ECG anomalies were found in 14 (56%). First-degree atrioventricular block (AVB) was seen in 5 (20%) patients a median of 6 (interquartile range 5–8) days after onset of fever and progressed to second- or third-degree AVB in 4 patients. No patient required intervention for AVB. All patients with AVB were admitted to the ICU (before onset of AVB) and had ventricular dysfunction on echocardiograms. All patients with second- or third- degree AVB had elevated brain natriuretic peptide levels, whereas the patient with first- degree AVB had a normal brain natriuretic peptide level. No patient with AVB had an elevated troponin level. -
Ventricular Tachycardia Associated Syncope in a Patient of Variant
Case Report http://dx.doi.org/10.4070/kcj.2016.46.1.102 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Korean Circulation Journal Ventricular Tachycardia Associated Syncope in a Patient of Variant Angina without Chest Pain Soo Jin Kim, MD, Ji Young Juong, MD, and Tae-Ho Park, MD Department of Cardiology, Dong-A University Medical Center, Busan, Korea A 68-year-old man was admitted for a syncope workup. After routine evaluation, he was diagnosed with syncope of an unknown cause and was discharged from the hospital. He was readmitted due to dizziness. On repeated Holter monitoring, polymorphic ventricular tachycardia was detected during syncope. We performed intracoronary ergonovine provocation test; severe coronary spasm was induced at 70% stenosis of the proximal left anterior descending artery. The patient was treated with percutaneous coronary intervention. We present a rare case of syncope induced by ventricular arrhythmia in a patient with variant angina without chest pain. (Korean Circ J 2016;46(1):102-106) KEY WORDS: Prinzmetal’s variant angina; Coronary vasospasm; Tachycardia, ventricular. Introduction Case Variant angina commonly manifests as chest pain and transient A 68-year-old man visited our emergency room due to recurrent ST elevation by coronary spasm, and generally follows a benign syncope. He had experienced four episodes of syncope with clinical course.1) Rarely, syncope induced by ventricular arrhythmia dizziness and chest discomfort during the prior 2 months. The associated with transient myocardial ischemia can be developed episodes were evoked when he was preparing his boat for sailing by coronary spasm.2)3) If the cause of syncope is not correctly in early morning. -
Cardiac Pacing in Incomplete Atrioventricular Block with Atrial Fibrillation
Br Heart J: first published as 10.1136/hrt.35.11.1154 on 1 November 1973. Downloaded from British Heart journal, I973, 35, I154-1I60. Cardiac pacing in incomplete atrioventricular block with atrial fibrillation D. S. Reid, S. J. Jachuck, and C. B. Henderson From the Department of Cardiology, Newcastle General Hospital, Newcastle upon Tyne Three cases with a slow irregular ventricular response to atrialfibrillation, who benefitedfrom cardiac pacing, are described; two had ischaemic heart disease, and one had cardiomyopathy. In thefirst case the slow ventricu- lar response to atrialfibrillation was a result of incomplete atrioventricular nodal block, and in the other two His bundle electrograms demonstrated that the slow ventricular response was due to bilateral bundle-branch block. The association of atrial fibrillation and conduction delays in the atrioventricular node and bundle- branches is discussed. The value of His bundle recordings in the investigation of these cases is shown and the importance of cardiac pacing in treatment is stressed. Cardiac pacing is now a generally accepted method hypotension. Intravenous atropine given before transfer of treatment in patients with complete heart block or had resulted in a paroxysm of ventricular tachycardia. bilateral bundle-branch block who have Adam- On admission there was no evidence of cardiac failure Stokes attacks or a low output to and the blood pressure was I05/50 mmHg. An electro- syndrome leading cardiogram showed atrial fibrillation with an irregular angina or cardiac failure. cardiac is However, pacing ventricular response of 40 to 44 beats a minute and acute now also becoming more widely used in the treat- inferolateral myocardial infarction (Fig. -
A Rare Case of Syncope Secondary to Sinus Node Dysfunction Associated with Brugada Syndrome Maya Khodor, MD1* and Joseph Chattahi, MD2
ISSN: 2378-2951 Khodor and Chattahi. Int J Clin Cardiol 2021, 8:223 DOI: 10.23937/2378-2951/1410223 Volume 8 | Issue 2 International Journal of Open Access Clinical Cardiology CASE REPORT A Rare Case of Syncope Secondary to Sinus Node Dysfunction Associated with Brugada Syndrome Maya Khodor, MD1* and Joseph Chattahi, MD2 1 American University of Caribbean, USA Check for 2Beaumont Hospital, Dearborn, Michigan, USA updates *Corresponding author: Maya Khodor, MD, American University of Caribbean, USA, Tel: 407-353-8875 diagnosed Brugada syndrome but was later found to Keywords have evidence of sinus node dysfunction. We review Brugada, Sinus node dysfunction, Syncope the relevant literature and discuss the management. Case Presentation Introduction A 31-year-old male with no significant past medi- Brugada Syndrome is a rare arrhythmogenic entity cal history presents after a witnessed syncopal episo- that poses a risk of sudden cardiac death due to ven- de. He denied any pre or post syncopal symptoms of tricular arrhythmias. Sinus node dysfunction is a less chest pain, palpitations, fevers, nausea, loss of bowel or recognized and acknowledged conduction abnormality associated with Brugada syndrome, but nevertheless bladder control or tongue biting. He does not take any an important potential manifestation that can alter ma- medications and denied any family history of sudden nagement. We present a case of a young patient who cardiac death. His physical exam and laboratory workup presented with syncope initially presumed to be secon- were unremarkable. His ECG showed sinus rhythm with dary to a ventricular arrhythmia in the setting of newly coved ST segment elevation and T wave inversions in Figure 1: ECG with normal sinus rhythm and type-1 Brugada pattern.